Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453518 · ClinicalTrials.gov registry record · NA
The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts
A NA study, sponsored by Lumen Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT00453518: Completed NA study, sponsored by Lumen Biomedical.
NCT00453518 is a NA study that has completed, run by Lumen Biomedical. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00453518, a NA study, has completed, sponsored by Lumen Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This is a multicenter, prospective study designed to demonstrate the performance and safety of the FiberNet Embolic Protection System when used as an adjunctive device during saphenous vein graft (SVG) intervention.
Interventions
- DEVICE FiberNet EPS used during SVG intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-02 |
| Phase | NA |
What the finished NCT00453518 record still lists
NCT00453518 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which FiberNet EPS used during SVG intervention. is the first listed.
NCT00453518 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00453518 about?
NCT00453518 is a clinical study titled "The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts". This is a multicenter, prospective study designed to demonstrate the performance and safety of the FiberNet Embolic Protection System when used as an adjunctive device during saphenous vein graft (SVG) intervention.
What is the current status of trial NCT00453518?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2007-03. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00453518?
The interventions under investigation include: FiberNet EPS used during SVG intervention. (DEVICE).
Who is sponsoring clinical trial NCT00453518?
This trial is sponsored by Lumen Biomedical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00453518's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia